Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2011-04-15

FDA Approved: LOTEMAX — Original Application (Bausch & Lomb Incorporated)

View source ↗

Summary

FDA approved Lotemax (loteprednol etabonate) under Original Application (NDA200738) for ophthalmic use to treat inflammatory conditions of the eye and for relie…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lotemax (Loteprednol etabonate)

Snippet

ORIG AP for LOTEMAX (LOTEPREDNOL ETABONATE)